Latest filing published 12 May 2026 for AbbVie Inc.. Read the official filing
No signal scores available.
All filings by Thomas J. Falk on record concern AbbVie Inc. Between 9 May 2025 and 8 May 2026, the trades on record add up to 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 12 May 2026: a share grant, in AbbVie Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations